For instance, Rong et al. (2016) demonstrated in vitro that T cells treated with exosomes derived from breast cancer cell lines exhibit reduced proliferation through a TGF-β-dependent mechanism that could be only partially reverted by treatment with anti-TGF-β antibodies. Here, TGFB1 is linked to breast cancer.